US Broker Ratings

Teleflex Incorporated (TFX) Stock Analysis: Insights on Potential Upside and Analyst Ratings

Teleflex Incorporated (NYSE: TFX), a dominant player in the healthcare sector, specializes in the design, development, and manufacture of single-use medical devices used in critical care..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech with a 46.52% Potential Upside

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 46.52% based on current analyst projections...

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a 195% Potential Upside for Biotechnology Investors

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biopharmaceutical landscape, presents a compelling opportunity for investors with its innovative approach to developing therapeutic and..

Atrium Therapeutics, Inc. (RNA): An Insightful Analysis of a Biotech Challenger with a $2.28 Billion Market Cap

Atrium Therapeutics, Inc. (RNA) presents a compelling narrative in the biotech sector, driven by its innovative approach to RNA therapeutics aimed at transforming cardiac care. With..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a 208.93% Potential Upside in Pioneering Biotech Ventures

Legend Biotech Corporation (NASDAQ: LEGN) stands out in the biotechnology sector, not only for its innovative advancements in cell therapy but also for its striking potential..

DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amid a 64.85% Return on Equity

DaVita Inc. (DVA), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is making waves with its impressive return on equity..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Promising Genetic Medicine Leader with 13.63% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is a burgeoning player in the biotechnology sector, making significant strides in the genetic medicine landscape. With a market cap of..

Glaukos Corporation (GKOS) Stock Analysis: Potential 11.95% Upside Amid Robust Revenue Growth

Glaukos Corporation (NYSE: GKOS), a notable player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its innovative therapies targeting..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth with a 7.05% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, continues to make strides in the competitive landscape of oncology treatment. With a focus on..

TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Growth with a 54.24% Return on Equity

TransMedics Group, Inc. (Nasdaq: TMDX) is rapidly gaining attention in the healthcare sector, specifically in the medical devices industry. The company is revolutionizing organ transplant therapy..

Oscar Health, Inc. (OSCR) Investor Outlook: Navigating a Potential 12.9% Upside Amid Mixed Analyst Ratings

Oscar Health, Inc. (OSCR), a healthcare technology company headquartered in New York, is garnering attention from investors due to its innovative approach to healthcare plans and..

BeOne Medicines Ltd. (ONC) Stock Analysis: 29.95% Potential Upside in Oncology Innovation

BeOne Medicines Ltd. (ONC), a Swiss-based biotech powerhouse, is capturing investors’ attention with its robust oncology-focused pipeline and impressive revenue growth. With a market capitalization of..

Alkermes plc (ALKS) Stock Analysis: Exploring a 45% Potential Upside in Biopharma

Alkermes plc (NASDAQ: ALKS) stands as a notable player in the biopharmaceutical sector, focusing on addressing unmet medical needs across a spectrum of therapeutic areas. Based..

BrightSpring Health Services (BTSG) Stock Analysis: A Promising 11.20% Upside Amid Robust Revenue Growth

BrightSpring Health Services, Inc. (BTSG) is capturing the attention of investors with a notable 11.20% potential upside, as indicated by its average target price of $46.07...

Sarepta Therapeutics, Inc. (SRPT) Investor Outlook: Understanding the 25.56% Upside Potential

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands at the forefront of the biotechnology industry, specializing in RNA-targeted therapeutics and gene therapies aimed at treating rare diseases. With..

Elanco Animal Health (ELAN) Stock Analysis: Navigating a 8.97% Potential Upside in the Booming Animal Health Market

Elanco Animal Health Incorporated (NYSE: ELAN) is making waves in the healthcare sector, specifically within the realm of specialty and generic drug manufacturing for animals. With..

Charles River Laboratories (CRL) Stock Analysis: Navigating the Healthcare Research Sector with 10.48% Upside Potential

For investors keen on the healthcare sector, Charles River Laboratories International, Inc. (NYSE: CRL) offers a unique blend of opportunities within the diagnostics and research industry...

Axsome Therapeutics (AXSM): Analyst Consensus Highlights 35% Potential Upside for This Biotech Innovator

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a New York-based biopharmaceutical company, continues to capture investor attention with its focus on developing therapies for central nervous system (CNS)..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Impressive Growth Potential Amidst Innovative Biotechnology Advances

Roivant Sciences Ltd. (ROIV), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its robust pipeline of clinical-stage biopharmaceuticals. Headquartered..

TG Therapeutics, Inc. (TGTX) Growth Potential: Navigating a 47.65% Upside in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX), a key player in the biotechnology sector, is making waves with its promising pipeline and substantial market potential. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds